News

Earlier this year, our parent company ValiRx announced the launch of Inaphaea BioLabs – a subsidiary company offering a wide range of pre-clinical and drug discovery testing services to academic, biotech, and pharmaceutical researchers. Inaphaea’s Preclinical Project Manager Zai Ahmad took on the task of setting up the new laboratory, drawing on her previous career…

Inaphaea has signed a Master Services Agreement and Project Statement of Work with a UK based biotech company. The first invoice has been issued relating to the work, with subsequent invoices anticipated at milestones during the project period. This defined work programme involves a multi-stage project and is expected to complete at the end of…

In the second instalment of our ‘meet the team’ series for Inaphaea BioLabs, we discover a little more about Melissa Barr.

Inaphaea are experts in developing immunoassays based on hormones and cytokines at our labs in MediCity, Nottingham as we strive to find new therapies in women’s health. In addition to our pre-validated models, our custom immunoassay services include the development, qualification, and validation of custom assays to meet your requirements. The types of assays we…

At our Inaphaea labs in MediCity, Nottingham we provide a comprehensive range of validated assays such as cell cancer assays or can provide assay development and validation for your bespoke assay as part of your project proposal. Cell-based assays play a crucial role in drug development and so at Inaphaea, we design the most relevant…

2023 is proving to be a busy year for ValiRx and Inaphaea, and our events schedule is no different, with the team attending events up and down the country to meet potential project partners and network with fellow life sciences professionals. 2023 events First up on ValiRx’s events calendar was BioEurope Spring which took place…